Mauro David J
Insider CIK 1621172 · ADXS Chief Medical Officer · RXRX Chief Medical Officer · CDAK Chief Medical Officer · PRLD Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2024-11-15 | 2024-11-19 | 4,187 | $6.18 | $25.9K | 225,429 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2024-08-15 | 2024-08-19 | 14,146 | $6.69 | $94.6K | 229,616 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2024-05-15 | 2024-05-17 | 867 | $10.01 | $8.7K | 243,762 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2024-02-09 | 2024-02-13 | 99,537 | — | $0 | 99,537 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2024-02-09 | 2024-02-13 | 1,892 | $10.09 | $19.1K | 244,629 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-02-09 | 2024-02-13 | 6,040 | — | $0 | 196,753 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-02-09 | 2024-02-13 | 49,768 | — | $0 | 246,521 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2023-06-01 | 2023-06-07 | 381,426 | — | $0 | 381,426 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-06-01 | 2023-06-07 | 190,713 | — | $0 | 190,713 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2023-01-24 | 2023-01-26 | 190,000 | — | $0 | 190,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2022-09-16 | 2022-09-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2022-05-02 | 2022-05-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2022-05-02 | 2022-05-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-10-05 | 2021-10-06 | 15,000 | — | $0 | 137,610 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2021-10-05 | 2021-10-06 | 15,000 | $1.89 | $28.4K | 15,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-10-05 | 2021-10-06 | 5,908 | $30.26 | $178.8K | 9,092 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-10-05 | 2021-10-06 | 7,803 | $31.30 | $244.2K | 1,289 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-10-05 | 2021-10-06 | 1,289 | $32.06 | $41.3K | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-09-07 | 2021-09-09 | 15,000 | — | $0 | 167,610 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-09-07 | 2021-09-09 | 4,640 | $37.79 | $175.3K | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2021-09-07 | 2021-09-09 | 15,000 | $1.89 | $28.4K | 15,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-09-07 | 2021-09-09 | 7,487 | $35.91 | $268.9K | 7,513 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-09-07 | 2021-09-09 | 2,873 | $36.92 | $106.1K | 4,640 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-08-05 | 2021-08-09 | 15,000 | — | $0 | 167,610 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-08-05 | 2021-08-09 | 2,063 | $31.03 | $64.0K | 6,821 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-08-05 | 2021-08-09 | 6,721 | $32.15 | $216.1K | 100 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-08-05 | 2021-08-09 | 100 | $32.63 | $3.3K | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-08-05 | 2021-08-09 | 6,116 | $29.93 | $183.1K | 8,884 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2021-08-05 | 2021-08-09 | 15,000 | $1.89 | $28.4K | 15,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2021-07-20 | 2021-07-22 | 95,000 | — | $0 | 95,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-07-06 | 2021-07-08 | 15,000 | — | $0 | 182,610 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-07-06 | 2021-07-08 | 10,445 | $27.17 | $283.8K | 4,555 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2021-07-06 | 2021-07-08 | 15,000 | $1.89 | $28.4K | 15,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-07-06 | 2021-07-08 | 4,255 | $28.13 | $119.7K | 300 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-07-06 | 2021-07-08 | 300 | $28.84 | $8.7K | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-06-07 | 2021-06-09 | 15,000 | — | $0 | 197,610 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-06-07 | 2021-06-09 | 12,700 | $32.73 | $415.7K | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-06-07 | 2021-06-09 | 1,400 | $30.35 | $42.5K | 13,600 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2021-06-07 | 2021-06-09 | 15,000 | $1.89 | $28.4K | 15,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-06-07 | 2021-06-09 | 900 | $31.62 | $28.5K | 12,700 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-05-05 | 2021-05-10 | 15,000 | — | $0 | 212,610 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-05-05 | 2021-05-10 | 3,415 | $39.36 | $134.4K | 11,585 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2021-05-05 | 2021-05-10 | 15,000 | $1.89 | $28.4K | 15,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-05-05 | 2021-05-10 | 1,109 | $41.07 | $45.5K | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-05-05 | 2021-05-10 | 10,476 | $40.30 | $422.2K | 1,109 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-04-27 | 2021-04-29 | 25,000 | — | $0 | 227,610 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-27 | 2021-04-29 | 1,711 | $36.11 | $61.8K | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2021-04-27 | 2021-04-29 | 25,000 | $1.89 | $47.3K | 25,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-27 | 2021-04-29 | 7,688 | $34.66 | $266.5K | 17,312 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-27 | 2021-04-29 | 15,601 | $35.68 | $556.6K | 1,711 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-04-19 | 2021-04-21 | 25,000 | — | $0 | 252,610 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-19 | 2021-04-21 | 4,000 | $31.27 | $125.1K | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2021-04-19 | 2021-04-21 | 25,000 | $1.89 | $47.3K | 25,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-19 | 2021-04-21 | 21,000 | $30.82 | $647.2K | 4,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-04-08 | 2021-04-15 | 9,617 | — | $0 | 277,610 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-08 | 2021-04-15 | 3,274 | $37.04 | $121.3K | 6,343 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2021-04-08 | 2021-04-15 | 9,617 | $1.89 | $18.2K | 9,617 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-08 | 2021-04-15 | 1,501 | $37.83 | $56.8K | 4,842 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-08 | 2021-04-15 | 1,293 | $39.00 | $50.4K | 3,549 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-08 | 2021-04-15 | 3,549 | $39.56 | $140.4K | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-04-07 | 2021-04-09 | 15,383 | — | $0 | 287,227 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2021-04-07 | 2021-04-09 | 15,383 | $1.89 | $29.1K | 15,383 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-07 | 2021-04-09 | 8,300 | $39.03 | $323.9K | 7,083 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-07 | 2021-04-09 | 7,083 | $39.69 | $281.1K | 0 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-12-31 | 2016-01-04 | 195 | $10.06 | $2.0K | 166,312 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2015-12-31 | 2016-01-04 | 41 | $10.06 | $412 | 166,271 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2015-11-30 | 2015-12-01 | 18 | $12.07 | $217 | 166,118 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-11-30 | 2015-12-01 | 108 | $12.07 | $1.3K | 166,136 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2015-11-05 | 2015-11-06 | 160,000 | — | $0 | 160,000 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2015-10-30 | 2015-11-03 | 21 | $11.09 | $233 | 166,028 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-10-30 | 2015-11-03 | 117 | $11.09 | $1.3K | 166,049 | SEC↗ |
| ADXS Advaxis, Inc. | S Sale | 2015-10-20 | 2015-10-22 | 24,586 | $10.08 | $247.8K | 165,932 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2015-09-30 | 2015-10-01 | 23 | $10.23 | $235 | 190,518 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-09-30 | 2015-10-01 | 127 | $10.23 | $1.3K | 190,541 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-08-31 | 2015-09-02 | 88 | $14.80 | $1.3K | 190,430 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2015-08-31 | 2015-09-02 | 16 | $14.80 | $237 | 190,414 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2015-07-31 | 2015-08-04 | 25 | $16.66 | $417 | 190,342 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-07-31 | 2015-08-04 | 117 | $16.66 | $1.9K | 190,367 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2015-06-30 | 2015-07-01 | 12 | $20.33 | $244 | 190,250 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-06-30 | 2015-07-01 | 64 | $20.33 | $1.3K | 190,262 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2015-05-29 | 2015-06-02 | 9 | $25.16 | $226 | 190,198 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-05-29 | 2015-06-02 | 51 | $25.16 | $1.3K | 190,207 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2015-04-30 | 2015-05-01 | 13 | $16.81 | $219 | 190,156 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-04-30 | 2015-05-01 | 76 | $16.81 | $1.3K | 190,169 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-03-31 | 2015-04-01 | 85 | $14.44 | $1.2K | 190,131 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2015-03-31 | 2015-04-01 | 38 | $14.44 | $549 | 190,093 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2015-03-30 | 2015-04-01 | 110,220 | — | $0 | 110,220 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2015-03-30 | 2015-04-01 | 6,062 | $13.44 | $81.5K | 190,046 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-03-30 | 2015-04-01 | 55,110 | — | $0 | 196,108 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-02-27 | 2015-03-02 | 136 | $9.00 | $1.2K | 141,030 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2015-02-27 | 2015-03-02 | 32 | $9.00 | $288 | 140,998 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-01-30 | 2015-02-04 | 186 | $9.85 | $1.8K | 140,953 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2015-01-30 | 2015-02-04 | 59 | $9.85 | $581 | 140,894 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2014-12-31 | 2015-01-02 | 25 | $8.01 | $200 | 135,788 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2014-12-31 | 2015-01-02 | 151 | $8.01 | $1.2K | 135,813 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2014-12-10 | 2015-02-04 | 9,796 | — | $0 | 145,584 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2014-12-10 | 2015-02-04 | 4,817 | $3.33 | $16.0K | 140,767 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2014-11-28 | 2014-12-01 | 388 | $3.12 | $1.2K | 135,723 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2014-11-28 | 2014-12-01 | 61 | $3.12 | $190 | 135,662 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2014-10-31 | 2014-11-03 | 190 | $3.18 | $604 | 135,360 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2014-10-31 | 2014-11-03 | 25 | $3.18 | $80 | 135,335 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2014-10-20 | 2014-10-21 | 165,000 | — | $0 | 165,000 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2014-10-20 | 2014-10-21 | 29,830 | $2.88 | $85.9K | 135,170 | SEC↗ |